glycyrrhizic acid has been researched along with Cognitive Decline in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, D; Kumar, A; Singh, A; Sinha, N | 1 |
| Abdel-Wadood, YA; Gomaa, AA; Gomaa, MA | 1 |
| Dong, S; Huang, H; Liu, C; Sha, H; Wei, W; Yu, M | 1 |
| Liu, SB; Qiu, C; Rong, Z; Sun, T; Wang, M; Wu, YM; Yu, W; Zhao, MG; Zheng, HS | 1 |
| Chen, X; Hua, HP; Kong, ZH; Liang, L; Liu, LJ | 1 |
1 review(s) available for glycyrrhizic acid and Cognitive Decline
| Article | Year |
|---|---|
Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild-moderate COVID-19 and prevention of post-COVID cognitive impairment.
Topics: Antiviral Agents; Cognitive Dysfunction; COVID-19 Drug Treatment; Dietary Supplements; Glycyrrhizic Acid; Humans; Molecular Docking Simulation; Pandemics; SARS-CoV-2 | 2022 |
4 other study(ies) available for glycyrrhizic acid and Cognitive Decline
| Article | Year |
|---|---|
High mobility group box 1 (HMGB1) inhibition attenuates lipopolysaccharide-induced cognitive dysfunction and sickness-like behavior in mice.
Topics: Animals; Cognitive Dysfunction; Cytokines; Glycyrrhizic Acid; HMGB1 Protein; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Mice; Nitric Oxide Synthase Type II; Nitrites; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2022 |
High mobility group box-1 mediates hippocampal inflammation and contributes to cognitive deficits in high-fat high-fructose diet-induced obese rats.
Topics: Animals; Apoptosis; Cognition; Cognitive Dysfunction; Diet, High-Fat; Glycyrrhizic Acid; Hippocampus; HMGB Proteins; HMGB1 Protein; Inflammation; Interleukin-1beta; Interleukin-6; Male; Microglia; NF-kappa B; Obesity; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2019 |
Activation of the Hippocampal LXRβ Improves Sleep-Deprived Cognitive Impairment by Inhibiting Neuroinflammation.
Topics: Animals; Anti-Inflammatory Agents; Benzoates; Benzylamines; Cognitive Dysfunction; Dose-Response Relationship, Drug; Glycyrrhizic Acid; Hippocampus; Liver X Receptors; Male; Mice; Mice, Inbred C57BL; Microinjections; Neuroinflammatory Diseases; Random Allocation; Sleep Deprivation | 2021 |
The Oral Pretreatment of Glycyrrhizin Prevents Surgery-Induced Cognitive Impairment in Aged Mice by Reducing Neuroinflammation and Alzheimer's-Related Pathology via HMGB1 Inhibition.
Topics: Administration, Oral; Alzheimer Disease; Animals; Anti-Inflammatory Agents; Brain; Cognitive Dysfunction; Cytokines; Disks Large Homolog 4 Protein; Glycyrrhizic Acid; HMGB1 Protein; Male; Maze Learning; Mice; Mice, Inbred C57BL; NF-kappa B; Splenectomy; tau Proteins; Toll-Like Receptor 4 | 2017 |